BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18785752)

  • 41. Atomic structures of anthrax toxin protective antigen channels bound to partially unfolded lethal and edema factors.
    Hardenbrook NJ; Liu S; Zhou K; Ghosal K; Zhou ZH; Krantz BA
    Nat Commun; 2020 Feb; 11(1):840. PubMed ID: 32047164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Domain 4 of the anthrax protective antigen maintains structure and binding to the host receptor CMG2 at low pH.
    Williams AS; Lovell S; Anbanandam A; El-Chami R; Bann JG
    Protein Sci; 2009 Nov; 18(11):2277-86. PubMed ID: 19722284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Domain flexibility modulates the heterogeneous assembly mechanism of anthrax toxin protective antigen.
    Feld GK; Kintzer AF; Tang II; Thoren KL; Krantz BA
    J Mol Biol; 2012 Jan; 415(1):159-74. PubMed ID: 22063095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anthrax protective antigen is a calcium-dependent serine protease.
    Storm L; Bikker FJ; Nazmi K; Hulst AG; der Riet-Van Oeveren DV; Veerman ECI; Hays JP; Kaman WE
    Virulence; 2018; 9(1):1085-1091. PubMed ID: 30052476
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Residue histidine 669 is essential for the catalytic activity of Bacillus anthracis lethal factor.
    Cao S; Guo A; Wu G; Liu Z; Chen W; Feng C; Zhang CC; Chen H
    J Bacteriol; 2010 Nov; 192(21):5799-805. PubMed ID: 20833809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different Roles of N-Terminal and C-Terminal Domains in Calmodulin for Activation of Bacillus anthracis Edema Factor.
    Lübker C; Dove S; Tang WJ; Urbauer RJ; Moskovitz J; Urbauer JL; Seifert R
    Toxins (Basel); 2015 Jul; 7(7):2598-614. PubMed ID: 26184312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of membrane translocation by anthrax protective antigen.
    Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
    Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A protective antigen mutation increases the pH threshold of anthrax toxin receptor 2-mediated pore formation.
    Dennis MK; Mogridge J
    Biochemistry; 2014 Apr; 53(13):2166-71. PubMed ID: 24641616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Receptor-specific requirements for anthrax toxin delivery into cells.
    Rainey GJ; Wigelsworth DJ; Ryan PL; Scobie HM; Collier RJ; Young JA
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13278-83. PubMed ID: 16141341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure and function of anthrax toxin.
    Lacy DB; Collier RJ
    Curr Top Microbiol Immunol; 2002; 271():61-85. PubMed ID: 12224524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of spontaneous deamidation on the cytotoxic activity of the Bacillus anthracis protective antigen.
    Zomber G; Reuveny S; Garti N; Shafferman A; Elhanany E
    J Biol Chem; 2005 Dec; 280(48):39897-906. PubMed ID: 16188881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Control of anthrax toxin gene expression by the transition state regulator abrB.
    Saile E; Koehler TM
    J Bacteriol; 2002 Jan; 184(2):370-80. PubMed ID: 11751813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of residues constituting the 2beta1 strand of domain II in the biological activity of anthrax protective antigen.
    Khanna H; Chopra AP; Arora N; Chaudhry A; Singh Y
    FEMS Microbiol Lett; 2001 May; 199(1):27-31. PubMed ID: 11356563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of new dominant-negative mutants of anthrax protective antigen using directed evolution.
    Wu G; Feng C; Cao S; Guo A; Liu Z
    Appl Biochem Biotechnol; 2012 Nov; 168(5):1302-10. PubMed ID: 22948605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma.
    Kintzer AF; Sterling HJ; Tang II; Abdul-Gader A; Miles AJ; Wallace BA; Williams ER; Krantz BA
    J Mol Biol; 2010 Jun; 399(5):741-58. PubMed ID: 20433851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.
    Mamillapalli S; Miyagi M; Bann JG
    Protein Sci; 2017 Feb; 26(2):355-364. PubMed ID: 27874231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure of anthrax lethal toxin prepore complex suggests a pathway for efficient cell entry.
    Fabre L; Santelli E; Mountassif D; Donoghue A; Biswas A; Blunck R; Hanein D; Volkmann N; Liddington R; Rouiller I
    J Gen Physiol; 2016 Oct; 148(4):313-24. PubMed ID: 27670897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Production and cell surface display of recombinant anthrax protective antigen on the surface layer of attenuated Bacillus anthracis.
    Wang YC; Yuan SL; Tao HX; Wang LC; Zhang ZS; Liu CJ
    World J Microbiol Biotechnol; 2015 Feb; 31(2):345-52. PubMed ID: 25504373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism.
    Kintzer AF; Sterling HJ; Tang II; Williams ER; Krantz BA
    PLoS One; 2010 Nov; 5(11):e13888. PubMed ID: 21079738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.